Pediatric non-clinical drug testing : principles, requirements, and practice / edited by Alan M. Hoberman, Elise M. Lewis.
"This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and ho...
Saved in:
Online Access: |
Full Text (via ProQuest) |
---|---|
Other Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Hoboken, N.J. :
John Wiley & Sons,
2012.
|
Subjects: |
MARC
LEADER | 00000cam a2200000Ma 4500 | ||
---|---|---|---|
001 | b9687755 | ||
003 | CoU | ||
005 | 20170929044539.8 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 111018s2012 njua ob 000 0 eng d | ||
019 | |a 775301847 |a 794619902 |a 898985096 |a 961515278 |a 962633257 |a 988497207 |a 991962611 | ||
020 | |a 9781118168264 |q (electronic bk.) | ||
020 | |a 1118168267 |q (electronic bk.) | ||
020 | |a 047044861X | ||
020 | |a 9780470448618 | ||
020 | |a 9781118168257 |q (electronic bk.) | ||
020 | |a 1118168259 |q (electronic bk.) | ||
020 | |z 9780470448618 |q (cloth) | ||
024 | 8 | |a 9786613620255 | |
028 | 0 | 1 | |a EB00062870 |b Recorded Books |
035 | |a (OCoLC)ebqac823731502 | ||
035 | |a (OCoLC)823731502 |z (OCoLC)775301847 |z (OCoLC)794619902 |z (OCoLC)898985096 |z (OCoLC)961515278 |z (OCoLC)962633257 |z (OCoLC)988497207 |z (OCoLC)991962611 | ||
037 | |a ebqac818510 | ||
040 | |a E7B |b eng |e pn |c E7B |d OCLCQ |d OCLCO |d N$T |d YDXCP |d CDX |d RECBK |d EBLCP |d CN3GA |d OCLCQ |d COO |d OCLCQ |d OCLCF |d AZK |d COCUF |d MOR |d PIFAG |d MERUC |d OCLCQ | ||
043 | |a n-us--- | ||
049 | |a GWRE | ||
050 | 4 | |a RM301.25 |b .P43 2012eb | |
245 | 0 | 0 | |a Pediatric non-clinical drug testing : |b principles, requirements, and practice / |c edited by Alan M. Hoberman, Elise M. Lewis. |
260 | |a Hoboken, N.J. : |b John Wiley & Sons, |c 2012. | ||
300 | |a 1 online resource (xv, 339 pages) : |b illustrations. | ||
336 | |a text |b txt |2 rdacontent. | ||
337 | |a computer |b c |2 rdamedia. | ||
338 | |a online resource |b cr |2 rdacarrier. | ||
504 | |a Includes bibliographical references. | ||
505 | 0 | |a Pediatric Nonclinical Drug Testing; Contents; Preface; Acknowledgments; Contributors; 1. Introduction; 2. Overview of Pediatric Diseases and Clinical Considerations on Developing Medicines for Children; 3. Nonclinical Safety Assessment for Biopharmaceuticals: Challenges and Strategies for Juvenile Animal Testing; 4. FDA Approach to Pediatric Testing; 5. Pediatric Drug Development Plans; 6. Application of Principles of Nonclinical Pediatric Drug Testing to the Hazard Evaluation of Environmental Contaminants; 7. Nonclinical Testing Procedures--Pharmacokinetics. | |
505 | 8 | |a 8. Preclinical Development of a Pharmaceutical Product for Children9. Juvenile Toxicity Study Design for the Rodent and Rabbit; 10. Dog Juvenile Toxicity; 11. Use of the Swine Pediatric Model; 12. Juvenile Immunodevelopment in Minipigs; 13. Use of Primate Pediatric Model; 14. Approaches to Rat Juvenile Toxicity Studies and Case Studies: a Pharmaceutical Perspective; Appendix 1 Maturation of Organ Systems in Various Species; Appendix 2 Sample Juvenile Toxicity Testing Protocol; Index. | |
520 | |a "This book explains the importance and practice of pediatric drug testing for pharmaceutical and toxicology professionals. It describes the practical and ethical issues regarding non-clinical testing to meet US FDA Guidelines, differences resulting from the new European EMEA legislation, and how to develop appropriate information for submission to both agencies. It also provides practical study designs and approaches that can be used to meet international requirements. Covering the full scope of non-clinical testing, regulations, models, practice, and relation to clinical trials, this text offers a comprehensive and up-to-date resource"--Provided by publisher. | ||
650 | 0 | |a Drug development |z United States. | |
650 | 0 | |a Pediatric pharmacology |z United States. | |
650 | 0 | |a Pediatrics |z United States |v Formulae, receipts, prescriptions |x Safety measures. | |
650 | 7 | |a Drug development. |2 fast |0 (OCoLC)fst00898670. | |
650 | 7 | |a Pediatric pharmacology. |2 fast |0 (OCoLC)fst01056473. | |
650 | 7 | |a Pediatrics. |2 fast |0 (OCoLC)fst01056503. | |
651 | 7 | |a United States. |2 fast |0 (OCoLC)fst01204155. | |
700 | 1 | |a Hoberman, Alan M. | |
700 | 1 | |a Lewis, Elise M. | |
776 | 0 | 8 | |i Print version: |t Pediatric non-clinical drug testing. |d Hoboken, N.J. : John Wiley & Sons, 2012 |w (DLC) 2011043323. |
856 | 4 | 0 | |u http://ebookcentral.proquest.com/lib/ucb/detail.action?docID=818510 |z Full Text (via ProQuest) |
907 | |a .b96877558 |b 07-02-19 |c 10-03-17 | ||
998 | |a web |b - - |c f |d b |e z |f eng |g nju |h 0 |i 1 | ||
956 | |a Ebook Central Academic Complete | ||
956 | |b Ebook Central Academic Complete | ||
999 | f | f | |i 57b14d2c-9ba3-5ad6-9002-6b6bc317e757 |s 4d51ea73-0136-5c62-8633-4b47d39723e9 |
952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e RM301.25 .P43 2012eb |h Library of Congress classification |i web |n 1 |